Hormonal therapies and venous thrombosis

Hormonal therapies and venous thrombosis: Considerations for ...

Thrombosis risk is seen with both hormonal contraceptive agents and with hormone replacement therapy for menopause and gender transition.

Hormonal therapies and venous thrombosis: Considerations for ...

Background: Venous thromboses are well-established complications of hormonal therapy. Thrombosis risk is seen with both hormonal contraceptive ...

Hormonal therapies and venous thrombosis: The estrogen matters ...

Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause

Hormonal therapies and venous thrombosis: Considerations for ...

Background Venous thromboses are well-established complications of hormonal therapy. Thrombosis risk is seen with both hormonal ...

Does hormone therapy exacerbate other venous thromboembolism

Hormone therapy exposure did not appear to adversely influence other risk factors, and exposure generally played a minor role in VTE risk.

Hormone Therapy and Venous Thromboembolism Among ...

Oral estrogen therapy increases the risk of venous thromboembolism (VTE) in postmenopausal women. Transdermal estrogen may be safer.

Use of hormone replacement therapy and risk of venous ... - The BMJ

Venous thromboembolism (VTE) is a rare but serious risk associated with hormone replacement therapy (HRT). HRT is used to prevent a range of ...

Hormone Therapy and the Risk of Venous Thromboembolism

This chapter reviews the risks of venous thromboembolism (VTE) associated with HT, including hormonal contraceptive preparations, postmenopausal HT, and ...

Hormone therapies and venous thromboembolism: where are we ...

While most research regarding the risk of venous thrombosis has been conducted on oral hormone use, an increasing number of studies are focusing on the ...

Female Hormones and Thrombosis - AHA Journals

Hormone replacement therapy increases the risk of venous thrombosis. This risk is also highest in the first year of use and among women with ...

Hormone therapy and venous thromboembolism - ScienceDirect.com

Convincing data from randomized trials and observational studies have demonstrated a two- to threefold increased risk of venous thromboembolism (VTE) with ...

Hormonal therapies and venous thrombosis: Estrogen matters!

Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause

Risk of Venous Thromboembolic Disease Associated With ...

Venous thromboembolic events (VTEs) represent a serious complication related to hormonal contraception and hormone replacement therapy (HRT). Evidence on.

Postmenopausal Estrogen Therapy Route of Administration and ...

Combination estrogen plus progestin hormone therapy (HT) or estrogen therapy (ET) for the management of menopausal symptoms and related disorders is associated ...

Hormone replacement therapy in women with history of thrombosis ...

The recent systematic review of vascular events when using micronized progesterone as part of cHRT found recurrent VTE risk was not affected by ...

Hormonal therapies in females with blood disorders: thrombophilia ...

Gonadal steroid hormones can be associated with an increased risk of thrombosis, and this risk will vary depending on the type of hormone therapy and dosage, as ...

Recurrent venous thromboembolism and abnormal uterine bleeding ...

Key Points. Estrogen-containing or progestin-only hormonal therapy is not associated with increased recurrent VTE risk in women on anticoagulant therapy.Ab.

Does the type of hormone replacement therapy influence the risk of ...

Background: Although hormone replacement therapy (HRT) is associated with an increased risk of deep vein thrombosis (DVT), it is not clear if the risk ...

Statin Use and the Risk of Venous Thromboembolism in Women ...

Importance Although hormone therapy (HT) in perimenopausal women is associated with increased risk for venous thromboembolism (VTE), ...

Hormone therapies and venous thromboembolism: where are we ...

Hormone therapies and venous thromboembolism: where are we now? J Thromb. Haemost 2011; 9: 257–66. Deep vein thrombosis is a common disease, with an incidence.